Stagezero Life Sciences Stock Current Asset
| SZLS Stock | CAD 0.04 0.00 0.00% |
StageZero Life Sciences fundamentals help investors to digest information that contributes to StageZero Life's financial success or failures. It also enables traders to predict the movement of StageZero Stock. The fundamental analysis module provides a way to measure StageZero Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to StageZero Life stock.
As of the 2nd of December 2024, Net Current Asset Value is likely to grow to about 73.1 K, while Non Current Assets Total are likely to drop about 474.6 K. StageZero | Current Asset |
StageZero Life Sciences Company Current Asset Analysis
StageZero Life's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
StageZero Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for StageZero Life is extremely important. It helps to project a fair market value of StageZero Stock properly, considering its historical fundamentals such as Current Asset. Since StageZero Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of StageZero Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of StageZero Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
StageZero Total Assets
Total Assets |
|
In accordance with the recently published financial statements, StageZero Life Sciences has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all Canada stocks is 100.0% higher than that of the company.
StageZero Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of StageZero Life from analyzing StageZero Life's financial statements. These drivers represent accounts that assess StageZero Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of StageZero Life's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 756.8K | 26.2M | 16.3M | 4.4M | 4.0M | 3.0M | |
| Enterprise Value | 3.1M | 23.2M | 15.9M | 6.2M | 5.6M | 5.8M |
StageZero Fundamentals
| Return On Equity | -1.69 | ||||
| Return On Asset | -0.64 | ||||
| Operating Margin | (0.57) % | ||||
| Current Valuation | 6.71 M | ||||
| Shares Outstanding | 123.55 M | ||||
| Shares Owned By Insiders | 19.99 % | ||||
| Number Of Shares Shorted | 39.71 K | ||||
| Price To Book | 5.94 X | ||||
| Price To Sales | 1.70 X | ||||
| Revenue | 2.88 M | ||||
| Gross Profit | 1.18 M | ||||
| EBITDA | (4.46 M) | ||||
| Net Income | (12.53 M) | ||||
| Cash And Equivalents | 754.87 K | ||||
| Total Debt | 1.8 M | ||||
| Current Ratio | 0.18 X | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (809.15 K) | ||||
| Short Ratio | 0.50 X | ||||
| Earnings Per Share | (0.16) X | ||||
| Target Price | 1.25 | ||||
| Number Of Employees | 40 | ||||
| Beta | 0.074 | ||||
| Market Capitalization | 4.94 M | ||||
| Total Asset | 700.65 K | ||||
| Retained Earnings | (123.04 M) | ||||
| Working Capital | (6.76 M) | ||||
| Net Asset | 700.65 K |
About StageZero Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze StageZero Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of StageZero Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of StageZero Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with StageZero Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if StageZero Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in StageZero Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to StageZero Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace StageZero Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back StageZero Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling StageZero Life Sciences to buy it.
The correlation of StageZero Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as StageZero Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if StageZero Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for StageZero Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in StageZero Stock
StageZero Life financial ratios help investors to determine whether StageZero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in StageZero with respect to the benefits of owning StageZero Life security.